RHONDA OWENS: Open Payments
NPI 1194290346 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 6 payments from 6 companies in 2025. Trend: 2023 $332 · 2024 $224 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Celgene Corporation | 1 | $29 |
| TerSera Therapeutics LLC | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
Products named: Epkinly, Fabhalta, REBLOZYL, Zoladex, KEYTRUDA, IMBRUVICA.
Industry payments across DE — which companies pay providers there.
